Teladoc Health (NYSE:TDOC – Get Free Report) issued an update on its second quarter 2024 earnings guidance on Thursday morning. The company provided earnings per share guidance of -0.450–0.350 for the period, compared to the consensus earnings per share estimate of -0.300. The company issued revenue guidance of $635.0 million-$660.0 million, compared to the consensus […]